 |
| PT Kalbe Farma Tbk / kalbe.co.id |
PT Kalbe Farma Tbk - Kalbe is the largest integtared pharmaceuticals company in Indonesia and South East Asia regions with total assets of Rp 11.31 trillion and a sales turnover of Rp16 trillion as at December 2013. Kalbe is a public-listed listed company and its shares are traded on the Indonesia Stock Exchange (IDX) since 1991 under reference KLBF. Headquartered in Jakarta, Kalbe now has 4 business portfolios, namely prescription pharmaceutical division, consumer health division, nutrition division, and distribution & logistics division. In term of distribution networks, the Public listed company supported by 2 Regional Distribution Centers, 68 branch offices spread in 50 cities throughout Indonesia. In 2013,
Kalbe achieved positive financial performance, where total net profit in 2013 is Rp1.92 trillion. This reflected an 10.7% increased compared to 2012 which was Rp1.73 trillion, according to its recently annual report (Kalbe Annual Report 2013) as cited by JobsCDC.com.
Due to facing fast business growth and expanding of business across Indonesia,
PT Kalbe Farma Tbk invites dynamic young professionals and high-power struggle to seize theese career opportunities
Biotech Engineer
Requirements
- Male / Female, with a maximum age of 25 years old.
- Have a Bachelor's degree (S1) majoring in Biotechnology, Chemistry Engineering, Pharmacy/Apothecary, Biology with a minimum cumulative GPA score of 3.00.
- Fluent in English with a minimum TOEFL score 500.
- Highly adaptable and willing to be stationed in Cikarang.
For further information, please refer official source from ITB Career Center on following link below. To apply, please register to karir.itb.ac.id and then submit your hardcopy CV to ITB Career Center Office - GKU Timur Lt. Dasar, Jl Ganesa No 10 Bandung 40132. Closing date 9 February 2015. Selection process (Psychotest) will be held on 10 February 2015. Only qualified candidates that meet with the above requirements would be processed in this recruitment. (JobsCDC.com /
Source)
